INS and inherited lipid metabolism disorder: However, the lack of FPI improvement with orforglipron warrants caution, as suppressed insulin levels in the context of weight loss may paradoxically exacerbate dyslipidaemia in susceptible individuals – a phenomenon observed in certain lifestyle intervention trials.